Monthly Archives: July 2014

Lessons From An IPO
July 22, 2014

Raising money is a huge part of being a CEO, but nothing can fully prepare you for the experience of taking your company public.   Together with our team at Zafgen, I recently had the experience of taking our company public

4 Comments

Framing Up Capital Efficiency In Early Stage Biotech
July 17, 2014

Capital efficiency has become a mantra at Atlas, one shared by a number of other early stage biotech investors. It’s a term often repeated in discussions about building young companies, and yet it has become clear that there’s no consistent

4 Comments

Patients: Our Purpose, Our Partners
July 9, 2014

My first experience in this life sciences industry, many years ago, was working as a pharmacist in a small town in the midwest. My most valued memories from that time were the instances when I was able to engage directly

2 Comments

Growing Beyond The Startup Phase: Lessons learned
July 1, 2014

So your biotech startup’s graduated to a Series A financing and your investors believe there’s nothing but champagne and robust clinical data in your future. Some classic analogies are applicable here; you’ve found a way off the island, you’ve defeated

Leave a comment